Kintara Therapeutics Inc [NASDAQ: KTRA] slipped around -0.01 points on Friday, while shares priced at $0.15 at the close of the session, down -5.82%. Compared to the average trading volume of 14.04M shares, KTRA reached a trading volume of 51140963 in the most recent trading
Kintara Therapeutics Inc [NASDAQ: KTRA] traded at a high on Tuesday, posting a 16.10 gain after which it closed the day’ session at $0.13. The results of the trading session contributed to over 7512848 shares changing hands. Over the past one week, the price volatility
Kintara Therapeutics Inc [NASDAQ: KTRA] plunged by -$0.01 during the normal trading session on while it closed the day at $0.13. The company report on April 3, 2024 at 7:00 AM that Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement. TuHURA is planning
Kintara Therapeutics Inc [NASDAQ: KTRA] surged by $0.01 during the normal trading session on while it closed the day at $0.10. The company report on March 27, 2024 at 9:00 AM that Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab.
Kintara Therapeutics Inc [NASDAQ: KTRA] loss -0.33% on the last trading session, reaching $0.09 price per share at the time. The company report on March 27, 2024 at 9:00 AM that Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab. Kintara
Kintara Therapeutics Inc [NASDAQ: KTRA] stock went on an upward path that rose over 46.05% on Wednesday, amounting to a one-week price increase of more than 28.26%. The company report on February 14, 2024 at 4:07 PM that Kintara Therapeutics Announces Fiscal 2024 Second Quarter
Kintara Therapeutics Inc [NASDAQ: KTRA] price surged by 7.68 percent to reach at $0.0. The company report on February 14, 2024 at 4:07 PM that Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update. Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or
Kintara Therapeutics Inc [NASDAQ: KTRA] closed the trading session at $0.10. The company report on February 14, 2024 at 4:07 PM that Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update. Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a
Kintara Therapeutics Inc [NASDAQ: KTRA] loss 0.00% on the last trading session, reaching $0.10 price per share at the time. The company report on February 14, 2024 at 4:07 PM that Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update. Kintara
Kintara Therapeutics Inc [NASDAQ: KTRA] stock went on a downward path that fall over -5.22% on Monday, amounting to a one-week price decrease of less than -2.40%. The company report on February 12, 2024 at 9:00 AM that Kintara Therapeutics Announces Initiation of REM-001 Clinical
© 2024, Powered by Smart TechOne
